Cynomolgus HGF R / c-MET Protein, His Tag, low endotoxin (MALS verified)

Customer Reviews
Cat. No. / Size
Price
Qty
MET-C52H9-100ug
$360.00
MET-C52H9-1mg (500ug X 2)
$2380.00
ETA of in-stock products:2 business days

Product Details

  • Synonym

    MET, AUTS9, HGFR, RCCP2, c-Met

  • Source

    Cynomolgus HGF R, His Tag (MET-C52H9) is expressed from human 293 cells (HEK293). It contains AA Glu 25 - Asn 930 (Accession # A0A2K5UM36-1).

    Predicted N-terminus: Glu 25

    Request for sequence
  • Molecular Characterization

    HGF R Structure

    Other Tags and Version Biotin & Other Labeled Version

    This protein carries a polyhistidine tag at the C-terminus.

    The protein has a calculated MW of 103.2 kDa. The protein migrates as 80 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE).

  • Endotoxin

    Less than 0.01 EU per μg by the LAL method / rFC method.

  • Purity

    >90% as determined by SDS-PAGE.

    >90% as determined by SEC-MALS.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in PBS, 0.2 M Arginine, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Storage

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Customers Also Viewed

Performance Data

  • SDS-PAGE

    HGF R SDS-PAGE

    Cynomolgus HGF R, His Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90% (With Star Ribbon Pre-stained Protein Marker).

  • SEC-MALS

    HGF R SEC-MALS

    The purity of Cynomolgus HGF R, His Tag (Cat. No. MET-C52H9) is more than 90% and the molecular weight of this protein is around 110-140 kDa verified by SEC-MALS.

    Report
  • Bioactivity-ELISA

     HGF R ELISA

    Immobilized Cynomolgus HGF R, His Tag (Cat. No. MET-C52H9) at 5 μg/mL (100 μL/well) can bind Human HGF, Fc Tag (Cat. No. HGF-H5253) with a linear range of 0.6-20 ng/mL (QC tested).

    Protocol
  •  HGF R ELISA

    Immobilized Human HGF, Fc Tag (Cat. No. HGF-H5253) at 2 μg/mL (100 μL/well) can bind Cynomolgus HGF R, His Tag (Cat. No. MET-C52H9) with a linear range of 0.039-1.25 μg/mL (Routinely tested).

    Protocol
  • Bridging ELISA

     HGF R BRIDGING ELISA

    Validated with Bispecific Antibody.
    Immobilized Rhesus macaque EGF R Protein, Fc Tag (Cat. No. EGR-C5252) at 10 μg/mL, add increasing concentrations of Amivantamab and then add Cynomolgus HGF R Protein, His Tag (Cat. No. MET-C52H9) at 5 μg/mL. Detection was performed using HRP conjugated Anti-His Antibody (AY63), mAb (Cat. No. HIS-PLM535) with sensitivity of 0.02 μg/mL (Routinely tested).

Customer Reviews
Writing Reviews

Background

Hepatocyte growth factor receptor (HGFR) is also known as mesenchymal-epithelial transition factor (MET), c-Met, and is a glycosylated receptor tyrosine kinase that plays a central role in epithelial morphogenesis and cancer development. HGFR protein possesses tyrosine-kinase activity. The primary single chain precursor protein is post-translationally cleaved to produce the alpha and beta subunits, which are disulfide linked to form the mature receptor. HGFR is normally expressed by cells of epithelial origin, while expression of HGF is restricted to cells of mesenchymal origin. Upon HGF stimulation, HGFR induces several biological responses that collectively give rise to a program known as invasive growth. Abnormal HGFR activation in cancer correlates with poor prognosis, where aberrantly active HGFR triggers tumor growth, formation of new blood vessels (angiogenesis) that supply the tumor with nutrients, and cancer spread to other organs (metastasis). HGFR is deregulated in many types of human malignancies, including cancers of kidney, liver, stomach, breast, and brain. Normally, only stem cells and progenitor cells express HGFR, However, cancer stem cells are thought to hijack the ability of normal stem cells to express HGFR, and thus become the cause of cancer persistence and spread to other sites in the body. Various mutations in the HGFR gene are associated with papillary renal carcinoma. HGFR mediates a complex program known as invasive growth. Activation of HGFR triggers mitogenesis, and morphogenesis.

Recent Advances

 
Drug Development Progress
  • English Name:

    Hepatocyte growth factor receptor

  • Category:

  • Approved Drugs:

    13 Details

  • Drugs in Clinical Trials:

    74 Details

  • Highest Development Stage:

    Approved

Contact Us
Drug Candidate Licensing
More
  • Basic Product Information
  • Product Details
  • Customers Also Viewed
  • Performance Data
  • Customer Reviews
  • Background
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland